{"id":"https://openalex.org/W2114809015","doi":"https://doi.org/10.2174/1381612819666140110115227","title":"Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation","display_name":"Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-09","ids":{"openalex":"https://openalex.org/W2114809015","doi":"https://doi.org/10.2174/1381612819666140110115227","mag":"2114809015","pmid":"https://pubmed.ncbi.nlm.nih.gov/24410567"},"language":"en","primary_location":{"id":"doi:10.2174/1381612819666140110115227","doi":"https://doi.org/10.2174/1381612819666140110115227","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612819666140110115227","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2114809015"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057976228","display_name":"Jane Pei\u2010Chen Chang","orcid":"https://orcid.org/0000-0001-5582-0928","observed_orcids":["https://orcid.org/0000-0001-5582-0928"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jane Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113638776","display_name":"Hsien\u2010Yuan Lane","orcid":"https://orcid.org/0000-0003-2162-8174","observed_orcids":["https://orcid.org/0000-0003-2162-8174"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hsien-Yuan Lane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036342199","display_name":"Guochuan Emil Tsai","orcid":"https://orcid.org/0000-0002-5124-3841","observed_orcids":["https://orcid.org/0000-0002-5124-3841"]},"institutions":[{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guochuan Tsai","raw_affiliation_strings":["Department of Psychiatry, Harbor-UCLA Medical Center, and the Los Angeles Biomedical Research Institute, Torrance, CA, USA. etsai@labiomed.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harbor-UCLA Medical Center, and the Los Angeles Biomedical Research Institute, Torrance, CA, USA. etsai@labiomed.org","institution_ids":["https://openalex.org/I177607063","https://openalex.org/I4210165985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8957,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93488406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"20","issue":"32","first_page":"5180","last_page":"5185"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nmda-receptor-dysfunction","display_name":"NMDA receptor dysfunction","score":0.8389999866485596},{"id":"https://openalex.org/keywords/glutamate-receptors","display_name":"glutamate receptors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/glutamatergic-system","display_name":"glutamatergic system","score":0.8460000157356262},{"id":"https://openalex.org/keywords/adhd-pathogenesis","display_name":"ADHD pathogenesis","score":0.8830000162124634},{"id":"https://openalex.org/keywords/brain-development","display_name":"brain development","score":0.8510000109672546},{"id":"https://openalex.org/keywords/impulse-inhibition","display_name":"impulse inhibition","score":0.9470000267028809},{"id":"https://openalex.org/keywords/treatment-resistant-adhd","display_name":"treatment-resistant ADHD","score":0.7480000257492065},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.7821494340896606},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.7805564999580383},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6176117062568665},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5751783847808838},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5690730810165405},{"id":"https://openalex.org/C2779388368","wikidata":"https://www.wikidata.org/wiki/Q3450985","display_name":"Neurodevelopmental disorder","level":3,"score":0.42045295238494873},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4170050621032715},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4138747751712799},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35763829946517944},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20861423015594482},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14806079864501953},{"id":"https://openalex.org/C205778803","wikidata":"https://www.wikidata.org/wiki/Q38404","display_name":"Autism","level":2,"score":0.11480322480201721}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007175","descriptor_name":"Impulsive Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016202","descriptor_name":"N-Methylaspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612819666140110115227","doi":"https://doi.org/10.2174/1381612819666140110115227","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612819666140110115227","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:24410567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24410567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386030222","https://openalex.org/W2763309798","https://openalex.org/W2228307021","https://openalex.org/W1530918435","https://openalex.org/W2929353116","https://openalex.org/W7117571089","https://openalex.org/W4226227374","https://openalex.org/W2139839376","https://openalex.org/W2083331867","https://openalex.org/W2766303140"],"abstract_inverted_index":{"Attention":[0],"deficit":[1],"hyperactivity":[2],"disorder":[3],"(ADHD)":[4],"is":[5],"a":[6,84,123],"long":[7],"recognized":[8],"and":[9,22,31,72,94],"common":[10],"childhood":[11],"disorder.":[12],"ADHD":[13,26,86,107],"adolescents":[14],"tend":[15],"to":[16,53],"encounter":[17],"more":[18,29],"difficulties":[19],"in":[20],"school":[21],"peer":[23],"relationships,":[24],"whereas":[25],"adults":[27],"have":[28],"occupational":[30],"interpersonal":[32],"difficulties.":[33],"However,":[34],"with":[35,129],"the":[36,47,101,114],"treatment":[37,125],"of":[38,46,60,90,103,110],"central":[39],"nervous":[40],"system":[41],"(CNS)":[42],"stimulants,":[43],"10-20":[44],"%":[45],"patients":[48,128],"still":[49],"remain":[50],"poor":[51],"responders":[52],"treatment.":[54],"Among":[55],"hypotheses":[56],"for":[57,106,127],"ADHD,":[58],"dysfunction":[59,82],"N-methyl-D-aspartate":[61],"(NMDA)-type":[62],"glutamate":[63],"receptors":[64],"has":[65],"recently":[66],"been":[67],"suggested":[68],"by":[69],"accumulating":[70],"genetic":[71],"animal":[73],"studies.":[74],"This":[75],"article":[76],"systemically":[77],"reviews":[78],"evidence":[79],"supporting":[80],"NMDA":[81,119],"as":[83],"potential":[85],"pathogenesis":[87],"from":[88],"perspectives":[89],"neurodevelopment,":[91],"attentional":[92],"circuitry,":[93],"impulse":[95],"inhibition.":[96],"The":[97],"review":[98],"also":[99],"addresses":[100],"development":[102],"novel":[104],"treatments":[105],"via":[108],"modulation":[109],"glutamatergic":[111],"system,":[112],"particularly":[113],"NMDA/glycine":[115],"site.":[116],"These":[117],"so-called":[118],"enhancers":[120],"may":[121],"provide":[122],"new":[124],"option":[126],"ADHD.":[130]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2114809015","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
